Loading...

Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma

Pembrolizumab has been available for the treatment of radical resectable urothelial carcinoma (UC) when it is exacerbated after chemotherapy since December 2017 in Japan. However, the efficacy of chemotherapy for cases progressing after pembrolizumab is unclear. The present study compared the outcom...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: Furubayashi, Nobuki, Hori, Yoshifumi, Morokuma, Futoshi, Tomoda, Toshihisa, Negishi, Takahito, Inoue, Tomohiro, Kumagai, Masatoshi, Kuroiwa, Kentaro, Tokuda, Noriaki, Nakamura, Motonobu
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7976390/
https://ncbi.nlm.nih.gov/pubmed/33767860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2021.2253
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!